NPs & PAs—Six Reasons Why They Need to Be Part of Your Strategy
In our rapidly changing healthcare system, the importance of PAs and NPs continues to grow in step with their increased contribution to patient care. Sponsor:
Wolters Kluwer
|
Run the Trial You Want
This paper will focus on the challenges with collecting data required for a protocol and best practices to address them. Learn how to meet the demands of modern trials with modern, cloud based electronic data capture (EDC) systems that enable you to run the trial you want.
Sponsor:
Veeva Systems
|
THE IMPORTANCE OF STAKEHOLDER RESEARCH IN RARE DISEASE DRUG DEVELOPMENT
The approval of novel orphan drug designations continues to grow, while many existing rare disease therapies are receiving approval for expanded indications. Sponsor:
Covance
|
Driving Great Access to Healthcare Professional and Increasing Brand Performance. How Virtual Engagement is Becoming a Must Have Component of any Pharmaceutical Sales Strategy
Virtually engaging Healthcare Professionals in a meaningful dialogue provides deeper engagements, opening up more possibilities for the delivery of brand and disease information for providers. Sponsor:
Trialcard
|
Precision Medicine in Immuno-Oncology
The ongoing advances in cancer immunotherapy together with precision medicine may promise a bright future for patients. Learn about the two most common biomarkers in clinical trials that are critical for the drug development process.
Sponsor:
Covance
|
2017 Real-World Evidence Benchmark Survey
Deloitte’s 2017 Real-World Evidence Benchmark Survey shows that life sciences companies are making some progress in using RWE but still have opportunities to expand applications across the value chain, consider new channels to access RWD, and improve their overall capabilities.
Sponsor:
Deloitte LLP
|
Big Data, Big Opportunity in Life Sciences
In the life sciences realm, “Big Data” is not a buzzword; it’s an opportunity to improve efficiency, product effectiveness, and financial outcomes. In this article, hear from LexisNexis Health Care experts about why they believe Big Data can turn needs into opportunities for massive growth and unprecedented success at all levels.
Sponsor:
LexisNexis
|
Biologics Manufacturing – Is Your Company Ready?
Protein-based science will account for more than 25% of the bio-pharma global portfolio in the very near future. At the same time the shift in pharmaceutical manufacturing to more predictive and adaptive plants will aim to better serve patients, which leverage modular technology (POD), disposable components, Internet of Things, smart objects, remote control and augment reality The landscape
|
Understand and value complex IDNs
To succeed in today’s complex IDN market, life sciences organizations can leverage innovative data insights and analytics intelligence to increase commercial efficiency and effectiveness. Download the Case Study to learn how.
Sponsor:
LexisNexis
|
A roadmap for success: Seizing the commercial opportunity from big data in Life Sciences
A new white paper, based on interviews with industry experts, explores the current landscape for big data within commercial functions, the challenges of exploiting it and a roadmap for success. Readers can walk away with a better understanding on how to develop a big data strategy for brand leadership and the key steps to get there.
Sponsor:
Zephyr Health
|